THE Global Institute of Traditional Medicine, which will apply clinical research and testing to traditional Chinese medicine in an effort to better develop policy, market analysis, and commercialization, was launched in Beijing on December 8, the consortium of universities backing the project announced.
The institute is a research collaboration between Australia’s University of Adelaide, the Jiangxi University of
Traditional Chinese Medicine, the Shanxi University of Traditional Chinese Medicine, and Heilongjiang University of Chinese Medicine.
“Traditional Chinese medicine has been practiced in China for over 2,000 years and is already a massive global industry worth billions of dollars,” said the new director of the Global Institute of Traditional Medicine, Professor Julie Owens, University of Adelaide’s Pro Vice-Chancellor for Research Strategy.
The initial priorities at the University of Adelaide under the Global Institute of Traditional Medicine will be investigating traditional medicine-related treatments for glucose intolerance, which could lead to better therapy for diabetes, digestive health, and improved quality of beef meat, the university said.
“There is increasing evidence of therapeutic benefits from these medicines, but for a truly sustainable global market and widespread adoption in western countries, we need scientifically rigorous testing of the safety and efficacy, or not, of these medicines,” Owens said.
There also needs to be new ways of standardizing and optimizing production of the plants and herbs used, she added.
“There are traditional Chinese medicine therapies for most of the leading chronic diseases in the world—potentially we all have a lot to gain from the incorporation of these treatments or related products into modern western medicine,” Owens concluded.